Thonburi Medical Centre Public Co. Ltd.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. carries a market capitalization of 1.65B, placing it among publicly traded companies globally. Its enterprise value stands at 932.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. has 19.38M shares outstanding.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. trades at a trailing price-to-earnings ratio of 10.48. The price-to-sales ratio is 1.43, and the price-to-book ratio stands at 1.76.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. trades at an EV/EBITDA multiple of 3.88 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 4.96 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Thonburi Medical Centre Public Co. Ltd. trades at an EV/FCF ratio of 7.59, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 932.47M versus a market cap of 1.65B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. maintains a current ratio of 5.38, meaning it holds 5.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.38, indicating conservative leverage, while an interest coverage ratio of 805.96 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Thonburi Medical Centre Public Co. Ltd. posted a return on equity (ROE) of 17.76, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 17.01 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 14.48, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 17.67, useful for judging operating efficiency across full business cycles. The company generates approximately 1.50M in revenue per employee across its workforce of 766.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 66.27 indicates how many times Thonburi Medical Centre Public Co. Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Thonburi Medical Centre Public Co. Ltd. recorded 36.17M in income tax expense. That works out to an effective tax rate of 18.70, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 193.46M, leaving 157.29M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 19, 2026, Thonburi Medical Centre Public Co. Ltd.'s stock has declined approximately 0.59% over the past 52 weeks. The 50-day moving average sits at 84.20, while the 200-day moving average is 86.67.

Over the twelve months ended June 30, 2026, Thonburi Medical Centre Public Co. Ltd. generated 1.15B in revenue and converted that into 157.29M in net income, yielding earnings per share of 8.11. EBITDA reached 240.48M, while operating income came in at 187.86M.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. holds 718.77M in cash and equivalents against 3.58M in total debt, resulting in a net debt position of -145.77M. Total book value stands at 937.70M, with working capital of 686.00M providing operational flexibility.

Thonburi Medical Centre Public Co. Ltd. produced 184.41M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -61.82M in capital expenditures, free cash flow totaled 122.59M - equivalent to 6.32 per share.

Over the twelve months ended June 30, 2026, Thonburi Medical Centre Public Co. Ltd. posted a gross margin of 34.46, reflecting its pricing power and cost economics. The operating margin of 16.35 and net profit margin of 13.69 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Thonburi Medical Centre Public Co. Ltd. paid dividends of 0.00 per share. The dividend payout ratio of 0.00 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 7.44, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.48, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Thonburi Medical Centre Public Co. Ltd. shareholders.

Thonburi Medical Centre Public Co. Ltd.'s most recent stock split took place on September 30, 2013 with a 50:51 split ratio.

As of June 30, 2026, Thonburi Medical Centre Public Co. Ltd. has an Altman Z-Score of 7.82, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.